HST962 Medical Product Development
Partial list of expert interviews John Maraganore, PhD, Chief Executive Officer, Alnylam Arthur Coury, PhD, Professor, Chemical Engineering, Northeastern University Hongming Chen, ScD, Chief Scientific Officer, Kalarx John McDonough, Chief Executive Officer, T2 BioSystems Purnanand Sarma, PhD, President and Chief Executive Officer, TARIS Biomedical Paolo Bonato, PhD, Director, Motion Analysis Laboratory, Spaulding Rehabilitation Hospital Dennis Giesing, PhD, Chief Scientific Officer, TARIS Biomedical Hong-Ren Wang, PhD, Director, Materials Discovery and Characterization, Vertex Anthony Wood, PhD, Vice President and Worldwide Head of Medicinal Chemistry, Pfizer Mark Levin, Partner, 3rd Rock Ventures Byron Masi, PhD, Senior Scientist, Orthopedics & Sports Medicine Ed McNamara, Vice President, R&D and Operations ,Corvia Medical Colin Gardner, PhD, Consultant, Formerly the VP of Global Pharm. Dev., Merck Nathaniel Katz, MD, MS, President, Analgesic Solutions Katrine Bosley, Chief Executive Officer, Editas Sarah Kalil, Chief Operating Officer, T2 Biosystems John Knopf, PhD, Chief Executive Officer, Acceleron Cheryl Blanchard, PhD, President & Chief Executive Officer, MicroChips Biotech Patricia Hurter, PhD, Senior Vice President, CMC and Preclinical Development, Vertex JC Gutierrez-Ramos, PhD, Chief Executive Officer, Synlogic Nikolai Begg, PhD, Product Development Engineer, Gynecological Devices Steven Paul, MD, President & Chief Executive Officer, Voyager Therapeutics Janet Woodcock, MD, Director, Center for Drug Evaluation and Research, FDA Mark McClellan, MD, PhD, Director of the Margolis Center for Health Policy, Duke University